Viewing Study NCT00531414



Ignite Creation Date: 2024-05-05 @ 6:45 PM
Last Modification Date: 2024-10-26 @ 9:36 AM
Study NCT ID: NCT00531414
Status: COMPLETED
Last Update Posted: 2008-04-10
First Post: 2007-09-16

Brief Title: Inspiratory Flow Using the Osmohaler
Sponsor: Syntara
Organization: Syntara

Study Overview

Official Title: Inspiratory Flow and VOlumes in Asthmatic and Healthy Individuals Using the Osmohaler
Status: COMPLETED
Status Verified Date: 2008-04
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The OsmohalerTM is a registered device in Australia It is used to deliver a dry powder a commercial preparation of mannitol registered as AridolTM to test if a person has irritable airways such as active asthma

The overseas regulatory authorities need to know that people of all ages can achieve an adequate inspiratory flow through this device during a controlled deep inspiration Adequate flow is generally regarded as greater than 30 litres per minute in children and 60 litres per minute in adults The OsmohalerTM is a device with low resistance and is already in use in Australia to deliver mannitol However there is a need to document inspiratory flows through the device during a controlled deep inspiration The protocol requires subjects to perform a controlled deep inspiration from the device on three or five occasions No substance will be inhaled
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None